Le Lézard
Classified in: Health, Science and technology
Subject: ANW

Bee Populations Face New Risk as Replikin Counts for Q1 2018 Match the 2012 Count, which Preceded a 50% Bee Loss


BOSTON, Sept. 14, 2018 /PRNewswire/ -- Bee populations face a new risk as Replikin counts (gene Replikin Count = number of Replikins per 100 amino acids) dramatically increased in the first quarter of 2018 to the same level as 2012 when bee colonies suffered a 50% loss. 

A 22-fold increase from 1982 to 2012, the Replikin Count was 49.3, the highest, with a 50% associated loss of bee colonies. The latest Replikin Count, for Q1 2018, matched 2012 at 49.3, creating a potential new risk for bee populations. 

The peak Replikin Counts appeared over a two-year period, and the 'drop' was more gradual, probably because these data are global, with different starting times in different geographic locations. 

Detailed data will be presented at a lecture on September 26, 2018 at Boston University School of Medicine at 5 PM.

Between 2014 and 2017, the lower peak Replikin Counts of 38, 13, 7.1 and 3.8 appeared annually, and % Loss of colonies was lower, namely 34%, 41%, 40%, and 32%.                                             In the first quarter of 2018, however, the peak Count was again increased markedly, rising again surprisingly to exactly 49.3, and this was maintained in September 2018, suggesting a major % loss of colonies will follow.

There is still time to introduce any blockers or vaccines available for testing. Replikins, Ltd. has a Blocker-Vaccinetm available for trial before the bees enter their hives for the winter of 2018-2019.         

A comparable Replikins Blocker-Vaccinetm has been tested successfully in influenza H5N1 in chickens (Jackwood et al. Avian Diseases 2009).                                                                 

For further information, contact Samuel Bogoch, [email protected], replikins.com.  Tel 646-320-5910       

SOURCE Replikins Ltd


These press releases may also interest you

at 22:03
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 20:15
The partnership was unveiled internally at the Franchisor's annual convention in Las Vegas, NV in December 2023, eliciting...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 18:57
Tribe Property Technologies Inc. (the "Issuer" or the "Company") , a leading provider of technology-elevated property management solutions, today announced that it expects to complete and file its 2023 Annual Filings (as defined below) on or before...

at 18:47
The Korean Cultural Center New York (KCCNY), a branch of the Ministry of Culture, Sports and Tourism of the Republic of Korea, is proud to present a special exhibition "Whanki in New York," from May 2 to June 13, 2024. This exhibition commemorates...



News published on and distributed by: